Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Local Residents to Host Scotch & Sangria for Parkinson’s Research at Sear House in Closter, NJ, on Thursday, March 2

Proceeds From Fourth Annual Helping Hours Event Benefit Parkinson’s Foundation

WHAT:  Enjoy post-work cocktails to support the Parkinson’s cause. Parkinson’s Foundation board member, Stephanie Goldman and her fellow co-chairs are inviting their community to Scotch & Sangria, their fourth annual Helping Hours event. The evening will feature a special tasting of assorted scotch and sangria, gourmet dinner and silent auction. Proceeds benefit the Foundation.

WHO:  The Parkinson’s Foundation, led by event Co-Chairs Stephanie Goldman of Norwood, Amy Sole of Mountain Lakes and Doug Stern of Demarest, NJ. The evening is a signature Parkinson’s Foundation Helping Hours event, where friends can enjoy a night out while supporting Parkinson’s research. The mission of the Parkinson’s Foundation, formed in August 2016 by the merger of PDF and the National Parkinson Foundation, is to invest in promising scientific research that will end Parkinson’s disease and improve the lives of people with Parkinson’s, and their families, through improved treatments, support and the best care.

WHY:  Co-Chairs Ms. Goldman, Ms. Sole and Mr. Stern, formed this event in honor of their loved ones touched by Parkinson’s. Ms. Goldman adds, “There’s still no cure for Parkinson’s disease. That’s why my co-chairs and I are driven to bring our community together each year to raise more awareness and critical funds to support the Parkinson’s Foundation’s work to end Parkinson’s for the one million people in the US, who like my father, live with Parkinson’s disease.” Since 2014, the trio’s Helping Hours events have raised over $80,000 for Parkinson’s research.

WHEN:  Thursday, March 2, 7:00 PM to 10:00 PM.

WHERE:  Sear House, 411 Piermont Road, Closter, NJ 07624

Monday, January 30, 2017
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.